Tris Pharma

Tris' next-gen pain drug completes trio of clinical wins

Tris Pharma’s opioid alternative has scored a third win, providing the biotech with the data needed to take the pain relief drug to the FDA this year.

James Waldron Mar 6, 2025 8:30am

Tris shows its opioid alternative is less likely to be abused

Jan 28, 2025 10:53am

Tris' opioid alternative reduces post-surgery pain in phase 3

Jan 22, 2025 8:30am

Cerevel swaps CEO—Chutes & Ladders

May 5, 2023 9:30am

Back-to-back FDA rejections leave Vernalis reeling

Aug 7, 2017 7:49am

Vernalis falls after FDA knocks back cough-cold drug filing

Apr 21, 2017 6:09am